Shopping Cart
Remove All
Your shopping cart is currently empty
GAT211 (AZ-4) is a selective and potent cannabinoid 1 receptor (CB1R) orthosteric modulator (PAM) with high affinity for cAMP and β-arrestin2.GAT211 has IOP-lowering and antipsychotic effects and can be used in the study of epilepsy.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $30 | In Stock | In Stock | |
| 5 mg | $64 | In Stock | In Stock | |
| 10 mg | $97 | In Stock | In Stock | |
| 25 mg | $159 | In Stock | In Stock | |
| 50 mg | $233 | In Stock | In Stock | |
| 100 mg | $345 | In Stock | In Stock | |
| 500 mg | $833 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $71 | In Stock | In Stock |
| Description | GAT211 (AZ-4) is a selective and potent cannabinoid 1 receptor (CB1R) orthosteric modulator (PAM) with high affinity for cAMP and β-arrestin2.GAT211 has IOP-lowering and antipsychotic effects and can be used in the study of epilepsy. |
| In vitro | GAT211 limits dopamine D2 receptor-mediated extracellular signal-regulated kinase (ERK) phosphorylation in Neuro2a cells, while THC does not[2]. |
| In vivo | When administered alone, GAT211 treatment (0.3-3.0 mg/kg) dose-dependently reduces locomotor activity and acoustic startle response. GAT211 (3.0 mg/kg) also prevents MK-801-induced hyperlocomotion but has no significant effect on PPI impairment[2]. |
| Synonyms | GAT-211, GAT 211, AZ-4, AZ4, AZ 4 |
| Molecular Weight | 342.39 |
| Formula | C22H18N2O2 |
| Cas No. | 102704-40-5 |
| Smiles | [O-][N+](=O)CC(c1c([nH]c2ccccc12)-c1ccccc1)c1ccccc1 |
| Relative Density. | 1.31g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (233.65 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 3.3 mg/mL (9.64 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.